| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |